If you need more lookups,
subscriptions start at $34 USD/month.
Eustache Paramithiotis Location
Montreal, QC, CA
Eustache Paramithiotis Work
Vice President, Research and Development @ (January 2021 - Present)
Vice President Research And Development @ Caprion HistoGeneX (January 2020 - January 2021)
Vice President, Discovery @ Caprion Biosciences Inc. (January 2017 - December 2019)
Vice President, Biomarker Discovery and Diagnostics @ Caprion Biosciences Inc. (January 2013 - January 2017)
Senior Director, Cell and Molecular Biology @ Caprion Proteomics (January 2008 - January 2013)
Director, Cell and Molecular Biology @ Caprion Pharmaceuticals Inc. (January 2002 - January 2008)
Group Leader, Cell and Molecular Biology @ Caprion Pharmaceuticals (January 1998 - January 2002)
Eustache Paramithiotis Education
McGill University
PhD (Microbiology & Immunology)
1989-1994
Concordia University
Bachelor of Science (BSc) (Biology)
1985-1989
Eustache Paramithiotis Skills
Antigen presentation
Biochemistry
Biomarker Discovery
Biomarkers
Biotechnology
Cancer
Cell
Cell Biology
DNA sequencing
Drug Discovery
Flow Cytometry
Immunology
Infectious Diseases
Infectious disease
Life Sciences
Lifesciences
Metabolic disease
Microbiology
Molecular Biology
Proteomics
Systems Biology
Translational Medicine
Vaccines
systems immunology
Team Building
Customer Service
Management
Marketing
Teaching
Strategic Planning
Eustache Paramithiotis Summary
Eustache Paramithiotis, based in Montreal, QC, CA, is currently a Vice President, Research and Development at CellCarta. Eustache Paramithiotis brings experience from previous roles at Caprion HistoGeneX, Caprion Biosciences Inc. and Caprion Proteomics. Eustache Paramithiotis holds a 1989 - 1994 PhD in Microbiology & Immunology @ McGill University. With a robust skill set that includes Antigen presentation, Biochemistry, Biomarker Discovery, Biomarkers, Biotechnology and more. Eustache Paramithiotis has 2 emails on RocketReach.
Looking for a different Eustache Paramithiotis?
Find contact details for 700 million professionals.